[Leprosy and the nervous system (author's transl)].
D000328:Adult; D000917:Antibody Formation; D002493:Central Nervous System Diseases / Q000175:diagnosis; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007918:Leprosy / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D008297:Male; D009046:Motor Neurons; D009461:Neurologic Manifestations; D009468:Neuromuscular Diseases / Q000175:diagnosis; D010523:Peripheral Nervous System Diseases / Q000175:diagnosis; D012293:Rifampin / Q000627:therapeutic use
D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin
Lepra und Nervensystem.